4-(Bromomethyl)-1-cyclohexyl-2-(trifluoromethyl)benzene

It acts as a key building block that provides the 4-cyclohexyl-3-(trifluoromethyl)benzyl moiety, which is linked to an oxime fragment in the final steps of the synthesis. 4-(Bromomethyl)-1-cyclohexyl-2-(trifluoromethyl)benzene is a critical intermediate in the synthesis of Siponimod, a drug used for multiple sclerosis.